Abstract-Glucocorticoid binding to cytoplasmic and nuclear fractions and gluco corticoid-receptor complex binding to the nuclear fraction were investigated using rat liver. The glucocorticoid-receptor complex binding to the nuclear fraction was temperature-dependent, saturable, small in amount and of high affinity. The affinity and number of the glucocorticoid-receptor complex binding to the nuclear fraction were altered according to the glucocorticoid.
GIucocorticolds, like other steroid hormones, are thought to act by controlling the rate of synthesis of protein (1) . The glucocorticoids react with receptor proteins in the cytoplasm and form a steroid-receptor complex (2) (3) (4) . The steroid-receptor complex undergoes an energy-dependent activation, enter the nucleus, and bind to acceptor sites, which are thought to trigger nuclear mediated events that result in the biological responses (1) (2) (3) (4) . Good correlations have been obtained between relative physiological and pharmacological potencies of the gluco corticoids and their affinities for the receptors of the cytoplasm in tissues in vitro and ex vivo (5) . Non equivalence in glucocorticoid receptor complex binding to nuclear acceptors was reported (6) . Furthermore, a good correlation between the inhibition of nuclear glucocorticoid-receptor complex binding and loss of gene expression of casein in mammary glands in vitro was reported recently (7) . In the present study, we have characterized the binding of glucocorticoid-receptor complexes and glucocorticoids to the nuclear fraction in addition to the glucocorticoids binding sites of the cytoplasmic fraction in rat liver and showed the heterogeneity of these binding sites.
Materials and Methods
Male albino rats of the Wistar strain weighing 150-200 g were used throughout the experiments.
Preparation of cytoplasmic fraction: After decapitation, the liver was perfused via the vena cava inferior with 20 ml of ice-cold 0.9% NaCI. The liver was isolated and homogenized with 6 vol. of ice-cold 10 mM Tris-HCI (pH 7.5) buffer containing 1 mM EDTA and 2 mM dithiothreitol. Lipoprotein  removed  supernatant  was  obtained  by  centrifugation  of  the  homogenate  at  100,000xg for 60 min and lipid aspiration from the resultant supernatant, and it was used as the cytoplasmic fraction of rat liver.
Preparation of nuclear fraction: The nuclear fraction of rat liver was prepared according to the previously reported method (8) , with slight modifications.
The liver that was perfused with ice-cold 0.9% NaCI was homogenized in 2 vol. of 0.32 M sucrose containing 10 mM Tris-HCI (pH 7.5), 3 mM MgCl2 and 1 mM glutathione (buffer I) by a Teflon-glass homogenizer. The homogenate was filtered through two layers of silicon coated gauze. The filtrate was centrifuged at 800 x g for 10 min. After removal of the supernatant, the pellet was suspended with 4 vol. of buffer I and centrifuged again at 800xg for 10 min. Then, the resulting pellet was suspended with 3 vol. of buffer I, and 10 ml of this suspension was layered on 18 ml of 1.5 M sucrose containing 10 mM Tris-HCI (pH 7.5), 3 mM MgCl2, 25 mM KCI and 1 mM glutathione.
Following centrifugation at 20,000xg for 30 min, the pellet was obtained and suspended with buffer I at the original wet weight volume. This suspension was used as the nuclear fraction of liver for nuclear acceptor and receptor assay.
Assay of glucocorticoid binding to cyto plasmic fraction: The binding was carried out as previously reported (9) . Three hundred M of cytoplasmic fraction was incubated with tritiated glucocorticoid at 0°C for 2 hr. The reaction was terminated by addition of 500 iel of activated charcoal solution (11% charcoal and 0.1% dextran (MW 60,000-90,000)/10 mM Tris-HCI (pH 7.5)) and was then mixed for 15 sec. The mixture was centrifuged at 3,000 rpm for 10 min at 2'C. From the supernatant, 0.2 ml was transferred into a counting vial containing PCS-xylene (111) scintillation counting fluid. The radio activity found in the presence of 10 /cM nonlabeled glucocorticoid was considered to be nonspecifically bound tritiated gluco corticoid and was subtracted from each experimental value found in the absence of the nonlabeled glucocorticoid (total binding) to obtain the amount of specifically bound tritiated glucocorticoid.
As nonlabeled glucocorticoids, HC, DM and triamcinolone acetonide were used for the determination of specific binding of 3H-HC, 3H-DM and 3H-triamcinolone acetonide , respectively.
Five nM tritiated glucocorticoids were used for the measurement of the affinities of steroids. Specific bindings of these tritiated glucocorticoids were found to be 90-95% of the total bindings. These specific binding values increased linearly with the protein concentration up to 3 mg per assay and reached equilibrium within 100-120 min under these experimental conditions. The inhibition constants (K;) were determined by means of the equation proposed by Chen and Prusoff (10) .
Assay of glucocorticoid binding to nuclear fraction:
The binding activity of gluco corticoid to nuclear fraction was carried out by the exchange method of Anderson et al. (11) . Five hundreds iel of nuclear fraction was incubated with tritiated glucocorticoid at 0 and 30°C for 90 min unless otherwise noted. Following standing for 10 min at 4°C, 2 ml of 10 mM Tris-HCI (pH 7.5) containing 150 mM NaCI and 10% glycerol (buffer II) was added and mixed immediately. The mixture was centrifuged at 800 x g for 10 min, and the supernatant was discarded. This procedure was repeated twice. The pellet was suspended with buffer II and filtered through a Milipore HAWP (0.45 itm) filter under reduced pressure. The filter was placed in a counting vial containing PCS xylene scintillator. To obtain the specific binding of tritiated glucocorticoid, the radio activity found in the presence of 10 ,itM nonlabeled glucocorticoid was subtracted from the value of total binding as described above. The specific bindings of 3H-HC and 3H-DM to nuclear fraction were approxi mately 95 and 85%, respectively, of the total binding at both 0 and 30°C. (Fig. 2) . Similarly, 3H triamcinolone acetonide binding was in hibited by these glucocorticoids.
In contrast, 3H-HC binding was not completely inhibited by DM and triamcinolone acetonide, except for HC (Fig. 2) . Synthetic glucocorticoids, DM and triamcinolone acetonide, did not inhibit the 3H-HC binding completely. These inhibitory effects reached a plateau at 100 nM with 45% inhibition (Fig. 2) the above two synthetic glucocorticoids. 3H Triamcinolone acetonide-receptor complex slightly bound to the nuclear fraction at 0°C. The temperature dependency of the gluco corticoid-receptor complex binding to the nuclear fraction was most clearly observed with the triamcinolone acetonide-receptor complex (Fig. 4) . There was no clear temper ature dependence of 3H-HC-receptor com plex binding.
3H-Glucocorticoid binding to the nuclear fraction: 3H-Glucocorticoids binding to the nuclear fraction was also time and temper ature-dependent, while the temperature dependency was not as distinct as that for the glucocorticoid-receptor complex (Fig. 5 ). There was no difference in the amount of binding between HC and DM to the nuclear fraction. DM and HC bound to the nuclear fraction with a similar pattern at both 0 and 30°C, respectively. The Scatchard analysis showed approximately equal values of Bmax for 3H-HC and 3H-DM (Fig. 6 ). These Bmax values were significantly larger than that of the glucocorticoid-receptor complex. On the other hand, the affinities of 3H-HC and 3H DM were obviously lower than that of the glucocorticoid-receptor complex. The Kd value of the latter one was about one hundredth of the former ones. In addition, the specific binding of 3H-triamcinolone acetonide to the nuclear fraction was different from those of 3H-HC and 3H-DM (Fig. 6 ). 
Discussion
Numerous researchers have subdivided the binding sites of glucocorticoids by chromatographic analyses and suggested that the binding site of synthetic gluco corticoid is just one part of the sites which bind natural glucocorticoids (2, (15) (16) (17) (18) . Biological potencies of glucocorticoids have been explained by the affinity for the receptor, which is the only site that the synthetic glucocorticoids can bind (5) . Certainly, in this study, HC bound to the DM binding site, but DM bound only to a part of the HC binding sites and the affinities of gluco corticoids for the 3H-DM and 3H-tri amcinolone acetonide binding sites of the cytoplasmic fraction correlated approximately to their physiological and pharmacological potencies (1 ) . On the other hand, there has been a great deal of controversy concerning the demonstration of nuclear acceptor sites. Several investigators have shown that the nuclear binding of the steroid-receptor complex is a saturable phenomenon and suggested the existence of a specific acceptor site (3, 19, 20) , while others claimed that a limited number of specific sites does not exist and that nuclear saturation is an artifact (21-23).
Much of this conflict probably stems from the difficulty in detecting a small number of specific sites in the presence of a large number of non specific sites (24). Buller et al. (19) succeeded in demonstrating the saturability, the high affinity of a small amount of sites and tissue specificity of the progesterone-receptor complex binding to nuclei in vitro by limiting the nonspecific binding. Furthermore, recent studies have shown that activation does occur in the cell and is not just an in vitro artifact (25, 26) . In this study, we were able to observe the high affinity, saturable, small amount and temper ature-dependent glucocorticold -receptor complex binding by subtracting the non specific binding. It is wellknown that in mammals, one cell contains approximately 6 pg of DNA (27), and we were able to observe 300 fmoles per 100 i g DNA as the maximum binding of the DM-receptor com plex to the nuclear fraction.
From these results, we were able to calculate that one liver cell contains 18x10-23 moles of acceptor sites, that is 10,000 molecules of DM-receptor complexes bind to the acceptor per cell. This value was agreed with the binding of the progesterone-receptor com plexes to the oviduct nuclei (19 it may be considered that the nuclear binding of gluco corticoid-receptor complex plays an im portant role and the level of the binding is involved in the efficacy of the glucocorticoid. Free glucocorticoid bindings to the nuclear fraction were observed with a low affinity that was one-hundredth of that of the glucocorticoid-receptor complex, and there were no differences between HC and DM.
In the case of triamcinolone acetonide, however, the specific binding to the nuclear fraction was not observed. So, it seems that the free glucocorticoid binding to the nuclear fraction does not have a significant role in the biological action of glucocorticoid. It has been considered that the affinity of glucocorticoid to the receptor protein in the cytoplasm is the most important factor which is related to the physioloical and phar macological effect of the glucocorticoid (5). The present study suggests that the number of the binding sites of glucocorticoid receptor to nuclei may be involved in the efficacy of the glucocorticoid in addition to the affinity of the glucocorticoid to the receptor of the cytoplasm.
